55 results
424B8
NMRD
Nemaura Medical Inc
11 Sep 23
Prospectus unintentially filed late
4:41pm
. This regulation places significant responsibility on the sponsor of the clinical study including, but not limited to, choosing qualified investigators
PRE 14A
NMRD
Nemaura Medical Inc
10 Aug 23
Preliminary proxy
4:05pm
with management and one another directly. Under these circumstances, the directors believe designating a lead director to take on responsibility for functions … responsibility in their respective areas of expertise.
The Audit Committee assists the Board with the oversight of our financial reporting, independent
POS AM
0l8dto8 4bzzzmq625
3 Aug 23
Prospectus update (post-effective amendment)
4:08pm
424B4
xvsh058
15 May 23
Prospectus supplement with pricing info
4:31pm
CORRESP
089c ggwjm4qx2oo51h
11 May 23
Correspondence with SEC
12:00am
424B5
w9kmaj8rb3 12
1 Apr 22
Prospectus supplement for primary offering
4:29pm
CORRESP
yz4o ngup3
24 Mar 22
Correspondence with SEC
12:00am
424B5
u3aja64io68
23 Jul 21
Prospectus supplement for primary offering
4:28pm
8-K
EX-1.1
dy5q0ir7cvqpwh
23 Jul 21
Entry into a Material Definitive Agreement
4:22pm